Affymax to Present at BIO CEO and Investor Conference - Earthtimes (press release) PDF Print

Affymax’s product candidate, Hematide™, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. ...

read more

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.